Kevin Pong

Kevin Pong

Company: Anima Biotech

Job title: CBO


mRNA Lightning Platform – Discovery of Small Molecule mRNA Drugs & Their Mechanisms of Action 11:30 am

Target space opportunity: an overview of Anima’s mRNA biology modulators mRNA Lightning platform combines mRNA Biology automated screening labs with cloud-based AI mRNA image analysis Anima’s software integrates MOA visualizing and fingerprinting to calculate similarities to all previously seen MOAs in mRNA BiologyRead more

day: Day Two

Biopharma & Investment Partnerships Panel — Exploring the Future of RNA Investment & Collaborations Space for Small Molecules 11:00 am

The biopharmaceutical sector is considering small molecule medications as a vital component. This community thrives on strategic alliances, which allow for cross-functional sharing of knowledge, skills, and experience across different disciplines to truly advance RNA-targeted small molecule drugs to patients. This session is the ideal opportunity to get face-to-face time with many of the brightest…Read more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.